DBV Technologies SA (NASDAQ:DBVT)
| 5.65 Delayed Data As of Jan 15 |  +1.91 / +51.07%Today’s Change | 1.35 Today|||52-Week Range 13.02 | +115.65% Year-to-Date |
Latest DBVT News | Press Releases
| Why DBV Technologies Stock Popped Today Jan 15 / MotleyFool.com - Paid Partner Content | New Strong Sell Stocks for January 13th Jan 13 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 3.74 |
| Today’s open | 3.75 |
| Day’s range | 4.99 - 5.88 |
| Volume | 589,975 |
| Average volume (3 months) | 1,718,653 |
| Market cap | $619.6M |
Data as of 5:16pm ET, 01/15/2021
Growth & Valuation
| Earnings growth (last year) | +31.42% |
| Earnings growth (this year) | -6.78% |
| Earnings growth (next 5 years) | +17.50% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.77 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BCELAtreca Inc | -0.30 | -1.99% |
| --Oxford BioMedica PLC | -0.00 | -0.04% |
| AVXLAnavex Life Sciences... | -0.11 | -1.86% |
| CLXTCalyxt Inc | +1.04 | +20.63% |
Data as of 4:00pm ET, 01/15/2021
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$171.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Montrouge, Ile-de-france |
Forecasts
